(a).
Combination positive (n)/negative (n)/specificity (%) | 230/253/64.2% |
Tumors detected (n)/sensitivity (%) | 103/80.5% |
High-risk tumors detected (n)/sensitivity (%) | 47/94% |
Numbers of tumors missed (n)/NPV (%) | 25/90.1% |
Numbers of high-risk tumors missed (n)/NPV (%) | 3/98.8% |
Numbers of false positive tests (n)/PPV (%) | 127/44.7% |
Additional tumors detected (n)/additional high-risk tumors detected by uCyt+ (n) | 14/4 |